通过调节Nrf2-介导的NLRP3炎症酶轴,Epimedin C缓解了骨关节炎的发展
Changchang Liu1, Guangyu Duan1, Shengjie Xu1
1Nanjing Hospital of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, 155 Hanzhong Road, Qinhuai District, Nanjing, Jiangsu Province, China.
Heliyon
|December 17, 2024
概括
埃皮梅丁C (Epi C) 通过保护软骨细胞和减少炎症,显示出对骨关节炎 (OA) 的治疗潜力. 它通过激活Nrf2通路和抑制NLRP3炎症酶来起作用,提供了新的OA管理策略.
科学领域:
- 生物医学科学 生物医学科学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 骨关节炎 (OA) 是一种广泛的退行性关节疾病,导致严重的残疾.
- 目前的OA治疗有局限性,需要探索新的治疗药物.
- 埃皮梅丁C (Epi C) 是一种具有潜在抗炎和细胞保护性能的化合物.
研究的目的:
- 研究Epimedin C (Epi C) 对骨关节炎 (OA) 的治疗作用.
- 阐明Epi C在OA中的作用的潜在分子机制.
- 评估Epi C在OA管理中的潜力.
主要方法:
- 试验室内:用介质素-1β (IL-1β) 治疗的红细胞以模拟OA;评估细胞活力,细胞亡,炎症和细胞外基质 (ECM) 降解.
- 在体内:通过介质半关节 (DMM) 的不稳定性在小鼠中诱导骨关节炎;评估了软骨完整性和Epi C.的治疗效果.
- 机理学研究:研究了核因子红色素2相关因子2 (Nrf2) 和NOD类受体热蛋白域相关蛋白3 (NLRP3) 炎症酶激活的作用.
主要成果:
- 爱皮梅丁C (Epi C) 保护了红细胞免受IL-1β诱导的损伤,增强了活力并抑制了亡.
- 在实验室中,Epi C显示出抗炎作用,并保留了细胞外基质 (ECM) 完整性.
- 在体内,Epi C治疗在DMM诱导的OA小鼠中保存了软骨结构,激活了Nrf2并抑制了NLRP3炎症酶表达.
结论:
- 埃皮梅丁C (Epi C) 在骨关节炎 (OA) 的临床前模型中表现出显著的治疗疗效.
- 埃皮C的机制涉及对Nrf2-介导的NLRP3炎症酶途径的调节.
- 这些发现凸显了Epi C作为新型OA管理策略的有希望的候选人.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


